Related Experiment Video
Updated: Aug 15, 2025

10:10
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
1.5K
Secondary glaucoma following vitreo-retinal surgeries
Gowri P Kolipaka1, Aparna Rao2
1VST Center of Glaucoma Department, L. V. Prasad Eye Institute, KAR Campus, Hyderabad, Telangana, India.
Indian Journal of Ophthalmology
|January 2, 2023
Summary
Vitreoretinal surgery can increase intraocular pressure (IOP), leading to glaucoma. Understanding the cause of elevated IOP is key for managing glaucoma after these procedures.
Area of Science:
- Ophthalmology
- Retina and Vitreous Surgery
- Glaucoma Management
Background:
- Vitreoretinal surgeries, including scleral buckles and tamponades, frequently elevate intraocular pressure (IOP).
- Glaucoma is a common complication following vitreoretinal procedures, even with advanced surgical methods.
- Intravitreal injections (IVT) of steroids or anti-VEGF agents can also significantly raise IOP, particularly in predisposed glaucomatous eyes.
Purpose of the Study:
- To review the mechanisms causing secondary glaucoma after vitreoretinal surgery.
- To highlight diagnostic challenges and differentiate between various causes of elevated IOP.
- To discuss management strategies for refractory glaucoma post-vitreoretinal surgery.
Main Methods:
- Literature review of mechanisms leading to secondary glaucoma post-vitreoretinal surgery.
- Analysis of diagnostic challenges including clinical features, conjunctival scarring, and episcleral hardware.
- Discussion of IOP-altering effects of intravitreal injections (steroids, anti-VEGF).
Main Results:
- Vitreoretinal surgery and IVT injections are significant risk factors for secondary glaucoma.
- Distinguishing the cause of elevated IOP is critical for appropriate glaucoma management.
- Surgical management of glaucoma in these eyes is complicated by scarring and hardware.
Conclusions:
- Secondary glaucoma following vitreoretinal surgery requires careful diagnosis and tailored management.
- Anti-VEGF agents may impact IOP, necessitating monitoring in glaucoma patients.
- Newer surgical options and modifications are being explored for refractory cases.
Related Concept Videos
Glaucoma: Overview
677
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
677
Angle Closure Glaucoma: Treatment
608
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
608
Open Angle Glaucoma: Treatment
518
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
518

